Inhibition of Iron-Catalyzed Oxidations by Attainable Uric Acid and Ascorbic Acid Levels: Therapeutic Implications for Alzheimer’s Disease and Late Cognitive Impairment

Publisher： Karger

E-ISSN： 1423-0003|54|4|238-243

ISSN： 0304-324x

Source： Gerontology, Vol.54, Iss.4, 2008-03, pp. : 238-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Distinctive features of microsaccades in Alzheimer’s disease and in mild cognitive impairment

By Kapoula Zoi   Yang Qing   Otero-Millan Jorge   Xiao Shifu   Macknik Stephen   Lang Alexandre   Verny Marc   Martinez-Conde Susana  

AGE, Vol. 36, Iss. 2, 2014-04 ,pp. : 535-543

Springer Publishing Company

Access to resources Recommend Favorite

Dietary arachidonic acid: a Janus face actor in brain and Alzheimer’s disease?

By Pinchaud Katleen   Maguin-Gaté Katy   Olivier Jean-Luc  

OCL (Oilseeds, Crops, fats & Lipids), Vol. 25, Iss. 4, 2018-08 ,pp. : D406-D406

Edp Sciences

Access to resources Recommend Favorite

Uric Acid and Coronary Heart Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 22, Iss. 2, 1974-02 ,pp. : 86-87

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic compliance of nanomedicine in Alzheimer’s disease

By Wilson Barnabas  

Nanomedicine, Vol. 6, Iss. 7, 2011-09 ,pp. : 1137-1139

Future Medicine

Access to resources Recommend Favorite

Progression of Cognitive Impairment in Alzheimer's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 1, 1991-01 ,pp. : 39-45

John Wiley & Sons Inc

Access to resources Recommend Favorite